NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I believe that DCVax-L is DCVax-L regardless of what cancer it's being applied to. If NWBO remains independent I believe that all DCVax-L sales will ultimately come to them, but I believe they'll have one or more contract manufacturers that will handle all manufacturing, storage, and distribution of the vaccine as it's needed. The key is each vial of vaccine is identified to one, and only one patient. If a does is needed, sufficient vaccine is withdrawn, place in a small vial, and shipped cryogenically if required to where it will be administered. The larger vial identified to the patient, and their disease, would be returned to cryogenic storage.

I mentioned the vial being identified to the patient and their disease because if one patient were fighting more than once cancer, different vials of DCVax-L may be needed by the patient to fight different cancers, each would be made from the cancer being treated.

I don't believe that NWBO will sell the EDEN to anyone, I believe they'll be leased and the company will track every use, and every disposable cassette being provided for manufacture of the vaccine. I think a corporate computer will track every one of the vials of the vaccine that are generated. If a patient is deceased, the company will tell the organization maintaining the vial for the patient how it's to be disposed of.

I would suspect that any patient deemed to be cancer free, but with vaccine remaining in cryogenic stowage would maintain the vaccine in stowage as insurance should the cancer come out of remission.

Gary